Skip to main content
BNR logo

Burning Rock Biotech Limited

BNRNASDAQHealthcareDiagnostics & Research

$11.15Today:- (-)1Y +26.67%

As of Oct 26, 2026 close

Market cap
$121.09M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$6.79$41.72
Volume (live)
-
Avg. volume (3M)
31.93K

Burning Rock Biotech (BNR) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Burning Rock Biotech used CNY 28.44M of cash in operating activities and spent CNY 5.25M on capital expenditures. That left free cash flow of −CNY 33.69M.

Burning Rock Biotech Cash Flow Statement Analysis

Values in billions CNY

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Burning Rock Biotech Limited (BNR) - Annual data in billions CNY
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-0.06-0.35-0.65-0.97-0.80-0.41-0.17-0.18-0.13
Depreciation & Amortization0.020.050.130.120.050.030.030.020.02
Deferred Income Tax0.000.000.000.000.020.000.020.000.00
Stock Based Compensation0.010.160.260.330.280.170.020.010.00
Change in Working Capital-0.06-0.04-0.05-0.01-0.060.11-0.13-0.01-0.03
Change in Accounts Receivable-0.03-0.03-0.02-0.04-0.02-0.04-0.070.00-0.03
Change in Inventory0.000.000.06-0.02-0.07-0.01-0.01-0.030.00
Change in Accounts Payable0.010.02-0.030.02-0.010.030.000.000.01
Change in Other Working Capital0.020.03-0.020.000.040.11-0.050.02-0.01
Other Operating Activities0.020.030.060.070.040.000.000.000.01
Net Cash from Operating Activities-0.03-0.09-0.26-0.46-0.48-0.07-0.23-0.15-0.13
Investing Activities
Capital Expenditures-0.01-0.01-0.01-0.07-0.21-0.08-0.05-0.02-0.02
Acquisitions0.000.000.000.000.000.000.000.000.00
Purchases of Investments0.000.000.000.00-0.06-0.03-0.410.00-0.17
Sales/Maturities of Investments0.000.000.000.070.360.000.110.130.00
Other Investing Activities0.000.000.00-0.010.000.000.000.000.00
Net Cash from Investing Activities0.000.00-0.01-0.010.08-0.11-0.350.11-0.19
Financing Activities
Debt Repayment0.000.000.000.00-0.04-0.04-0.080.080.01
Common Stock Issued0.000.000.000.000.001.920.000.000.00
Common Stock Repurchased0.000.00-0.01-0.070.000.000.000.00-0.01
Other Financing Activities0.000.00-0.04-0.010.000.330.660.000.35
Net Cash from Financing Activities0.000.00-0.05-0.09-0.052.170.570.080.35
Summary
Effect of Forex Changes on Cash-0.010.000.000.04-0.04-0.160.010.00-0.01
Net Change in Cash-0.04-0.09-0.31-0.51-0.451.830.000.040.02
Cash at Beginning of Period0.520.620.931.441.930.100.100.050.04
Cash at End of Period0.480.520.620.931.441.930.100.100.05
Free Cash Flow-0.03-0.10-0.26-0.53-0.69-0.15-0.27-0.17-0.16
Supplemental Disclosures
Interest Paid---0.000.000.00---
Income Taxes Paid---0.000.00----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Burning Rock Biotech Cash Flow

What is Burning Rock Biotech's free cash flow?

Burning Rock Biotech had negative free cash flow of CNY 33.69M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −CNY 28.44M minus CNY 5.25M of capital expenditures.

How much does Burning Rock Biotech spend on capital expenditures?

Burning Rock Biotech spent CNY 5.25M on capital expenditures in fiscal 2025, compared with CNY 5.98M a year earlier.

Does Burning Rock Biotech pay dividends or buy back shares?

Burning Rock Biotech's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition